NYSE:JNJPharmaceuticals
Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow Yet Pricey On Earnings
Johnson & Johnson stock has delivered a 69.3% total return over the past five years, while current valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside and earnings-based multiples looking less generous.
Over the last five years, Johnson & Johnson has returned 69.3%, which puts more focus on whether today’s price still offers a margin of safety.
Progress in higher value medicines, including recent U.S. FDA Priority Review for...